| 24-May-2023 | D | In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on May 24, 2023 has transacted the following business: 1) Approved audited standalone results for the quarter and period ended March 31st, 2023; 2) Recommended the payment of 0.50 per equity share as Final Dividend for the financial year 2022-23 subject to approval of shareholders in the Annual General Meeting.
The record date for the purpose of final dividend shall be 18.09.2023
(As per BSE Announcement Dated on 01/09/2023) | 18-Sep-2023 | |
| 25-May-2022 | D | Final dividend of Rs0.50 per share recommended by the board subject to approval by the Shareholders in the Annual General Meeting | 08-Sep-2022 | |
| 02-Jul-2021 | D | Outcome of the Board Meeting held on 30.06.2021
Equity Rs.0.5000 per share(5%)Final Dividend
| 08-Sep-2021 | |
| 29-May-2018 | D | Board approves dividend on 29/05/2018 | 14-Sep-2018 | |
| 27-May-2017 | D | Lotus Eye Care Hospital Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2017, inter alia, has recommended a final dividend of Re. 0.50 (i.e. @ 5%) per equity share of Rs. 10/- each fully paid up of the Company for the financial year 2016-17 subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The final dividend would be paid within 30 days from the date of its declaration at the AGM. | 02-Aug-2017 | |
| 04-Nov-2024 | BC | Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve consideration of unaudited | 12-Nov-2024 | |
| 25-Sep-2024 | BC | Three independent Directors of Lotus Eye Hospital and Institute Limited cease to hold office due to completion of tenure of 10 years | 24-Sep-2024 | |
| 22-Jul-2024 | BC | Annual report as per Regulation 34(1)(a) of SEBI (LODR) 2015 | 13-Aug-2024 | |
| 12-Aug-2024 | BC | The Board of directors of the company at its meeting held on 12th august approved the unaudited standalone results for the quarter and financial year ended June 30th 2024 | 12-Aug-2024 | |
| 22-Jul-2024 | BC | Annual report as per Regulation 34(1)(a) of SEBI (LODR) 2015 | 07-Aug-2024 | |
Announcement Date24-May-2023
Ex Dividend Date18-Sep-2023
Dividend(%)5
Announcement Date25-May-2022
Ex Dividend Date08-Sep-2022
Dividend(%)5
Announcement Date02-Jul-2021
Ex Dividend Date08-Sep-2021
Dividend(%)5
Announcement Date29-May-2018
Ex Dividend Date14-Sep-2018
Dividend(%)5
Announcement Date27-May-2017
Ex Dividend Date02-Aug-2017
Dividend(%)5
No Bonus has been declared by LOTUSEYE
No Split has been declared by LOTUSEYE
RightsNo Rights has been declared by LOTUSEYE
Book Closure
| 12-Nov-2024 | - | Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve consideration of unaudited |
| 24-Sep-2024 | - | Three independent Directors of Lotus Eye Hospital and Institute Limited cease to hold office due to completion of tenure of 10 years |
| 13-Aug-2024 | - | Annual report as per Regulation 34(1)(a) of SEBI (LODR) 2015 |
| 12-Aug-2024 | - | The Board of directors of the company at its meeting held on 12th august approved the unaudited standalone results for the quarter and financial year ended June 30th 2024 |
| 07-Aug-2024 | 01 Jan'1900 | Annual report as per Regulation 34(1)(a) of SEBI (LODR) 2015 |